Inactivation of the p53 gene in leukemias and myelodysplastic syndrome (MDS) with 17p monosomy.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Leukemia

• Publication date

  1994-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 7808014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is inactivation of the p53 gene a common event in leukemias and myelodysplastic syndrome with monosomy 17p?

  1994cited by this paper
• Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.

  1994cited by this paper
• Clinical implications of the p53 tumor-suppressor gene.

  1993cited by this paper
• Mutations of the P53 gene in acute myeloid leukaemia

  1992cited by this paper
• Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis.

  1992cited by this paper
• P53 gene mutations in acute myeloid leukemia with 17p monosomy.

  1991cited by this paper
• p53 is frequently mutated in Burkitt's lymphoma cell lines.

  1991cited by this paper
• Mutations in the p53 gene in myelodysplastic syndromes.

  1991cited by this paper

• Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells

  2024cites this paper
• Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia

  2019cites this paper
• The mutational landscape and microenvironment in Myelodysplastic Syndromes with deletion of chromosome 5 q THESIS FOR DOCTORAL DEGREE ( Ph . D . )

  2018cites this paper
• Implications of TP53 Gene Mutations in Myelodysplastic Syndromes: A Review

  2015influential citation
• Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine.

  2014cites this paper
• TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.

  2011cites this paper
• Clinics and pathology Disease Acute non lymphocytic leuemia / myelodysplastic syndromes

  2011cites this paper
• del(17p) in myeloid malignancies

  2011cites this paper
• Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.

  2010cites this paper
• Ectopic expression of C/EBPα and ID1 is sufficient to restore defective neutrophil development in low-risk myelodysplasia

  2009cites this paper
• Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochemistry and DNA analysis.

  1999cites this paper
• In vitro effects of IL-12 and IL-2 on NK cells, cytokine release and clonogenic activity in myelodysplastic syndromes (MDS)

  1997cites this paper
• Cytogénétique des syndromes myélodysplasiques

  1996cites this paper
• Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes.

  1996cites this paper
• A case of refractory anaemia with p53 point mutation at codon 249 (AGG to ATG)

  1996cites this paper